These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2056071)

  • 1. Platelet-activating factor antagonists do not protect against the development of experimental autoimmune encephalomyelitis.
    Vela L; García Merino A; Fernández-Gallardo S; Sánchez Crespo M; López Lozano JJ; Saus C
    J Neuroimmunol; 1991 Jul; 33(1):81-6. PubMed ID: 2056071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain and spinal cord levels of histamine in Lewis rats with acute experimental autoimmune encephalomyelitis.
    Orr EL; Stanley NC
    J Neurochem; 1989 Jul; 53(1):111-8. PubMed ID: 2786054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.
    Feurer C; Prentice DE; Cammisuli S
    J Neuroimmunol; 1985 Dec; 10(2):159-66. PubMed ID: 3877741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of alprazolam on the development of acute experimental autoimmune encephalomyelitis in stressed rats.
    Núñez-Iglesias MJ; Novío S; Almeida-Dias A; Freire-Garabal M
    Pharmacol Biochem Behav; 2010 Dec; 97(2):350-6. PubMed ID: 20833196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
    Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of experimental autoimmune encephalomyelitis in Dark Agouti rats without adjuvant.
    Stosic-Grujicic S; Ramic Z; Bumbasirevic V; Harhaji L; Mostarica-Stojkovic M
    Clin Exp Immunol; 2004 Apr; 136(1):49-55. PubMed ID: 15030513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats.
    Kuroda Y; Shimamoto Y
    J Neuroimmunol; 1991 Nov; 34(2-3):159-64. PubMed ID: 1918322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cells in brains during experimental allergic encephalomyelitis in Lewis rats.
    Bø L; Olsson T; Nyland H; Krüger PG; Taule A; Mørk S
    J Neurol Sci; 1991 Oct; 105(2):135-42. PubMed ID: 1757789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor.
    Sasaki M; Lankford KL; Brown RJ; Ruddle NH; Kocsis JD
    Glia; 2010 Oct; 58(13):1523-31. PubMed ID: 20645414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis.
    Matsumoto Y; Kawai K; Tomita Y; Fujiwara M
    Immunology; 1990 Feb; 69(2):215-21. PubMed ID: 1689693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation into the possible involvement of platelet activating factor in experimental allergic encephalomyelitis in rats.
    Howat DW; Chand N; Braquet P; Willoughby DA
    Agents Actions; 1989 Jun; 27(3-4):473-6. PubMed ID: 2801340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of experimental allergic encephalomyelitis by alpha 2-macroglobulin.
    Hunter N; Weston KM; Bowern NA
    Immunology; 1991 May; 73(1):58-63. PubMed ID: 1710603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock proteins and experimental autoimmune encephalomyelitis (EAE): I. Immunization with a peptide of the myelin protein 2',3' cyclic nucleotide 3' phosphodiesterase that is cross-reactive with a heat shock protein alters the course of EAE.
    Birnbaum G; Kotilinek L; Schlievert P; Clark HB; Trotter J; Horvath E; Gao E; Cox M; Braun PE
    J Neurosci Res; 1996 May; 44(4):381-96. PubMed ID: 8739158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of acute and chronic experimental allergic encephalomyelitis in Strain 13 guinea pigs. A clinical and pathological study.
    Raine CS; Snyder DH; Stone SH; Bornstein MB
    J Neurol Sci; 1977 Apr; 31(3):355-67. PubMed ID: 845617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimmunomodulation by allogeneic seminal vesicle fluid in CNS is sex-independent.
    Pakravan N; Ghaffarinia A; Parvaneh S; Yaslianifard S; Jalili C; Riazi-Rad F
    Neurol Res; 2016 Feb; 38(2):103-9. PubMed ID: 27118606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor.
    Mohamed A; Shoker A; Bendjelloul F; Mare A; Alzrigh M; Benghuzzi H; Desin T
    Biomed Sci Instrum; 2003; 39():440-5. PubMed ID: 12724933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and histological findings in proteolipid protein-induced experimental autoimmune encephalomyelitis (EAE) in the Lewis rat. Distribution of demyelination differs from that in EAE induced by other antigens.
    Chalk JB; McCombe PA; Smith R; Pender MP
    J Neurol Sci; 1994 May; 123(1-2):154-61. PubMed ID: 7520480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental allergic encephalomyelitis supernatant transfer activity (EAE-STA) in Lewis rats:immunobiologic and initial biochemical properties.
    Whitacre CC; Paterson PY
    J Immunol; 1980 Apr; 124(4):1784-8. PubMed ID: 6965962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of circulating and cell-bound antibodies in experimental allergic encephalomyelitis.
    Gonatas NK; Gonatas JO; Stieber A; Lisak R; Suzuki K; Martenson RE
    Am J Pathol; 1974 Sep; 76(3):529-48. PubMed ID: 4547331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurointermediate pituitary lobectomy decreases the incidence and severity of experimental autoimmune encephalomyelitis in Lewis rats.
    Quintanar-Stephano A; Chavira-Ramírez R; Kovacs K; Berczi I
    J Endocrinol; 2005 Jan; 184(1):51-8. PubMed ID: 15642782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.